Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram plus tandospirone versus escitalopram alone for vascular depression with mild cognitive decline
ChiCTR2100051241Phase 4Completed
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of escitalopram and tandospirone in vascular depression (VD) (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: Hamilton Depression Rating Scale and Hamilton Anxiety Scale. Started Oct 2017; status: completed.
02
Drugs
escitalopramtandospirone
03
Conditions
vascular depression (VD)
Beyond the preview
Go deeper on ChiCTR2100051241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051241.